When blood flow is reduced or cut to tissues, cells are deprived of oxygen and nutrients, which can lead to cell death if blood flow isn’t efficiently restored. Stem cells are promising treatments, but they do not tend to stay at the site or survive long enough to heal the damage. Today in ACS Central Science, researchers combine micro and nano approaches to improve stem cell therapies and outcomes after ischemia, or inadequate blood supply.